Faculty of 1000 evaluation for Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

2013 ◽  
Author(s):  
Philip Rosenthal
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Phase 2 ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Double Blind ◽  
Phase 2 Trial ◽  
Pegylated Interferon Alfa

scholarly journals Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?

2007 ◽  
Vol 11 (6) ◽  
pp. 554-560 ◽  
Author(s):  
Giovanni Faria Silva ◽  
Rodrigo José Polônio ◽  
Maria Inês Moura Campos Pardini ◽  
Silvia Maria Corvino ◽  
Rita Maria Saccomano Henriques ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Different Populations ◽  
Pegylated Interferon Alfa
Sign in / Sign up

Export Citation Format

Share Document